Many psychiatric drugs modulate the nervous system through multitarget mechanisms. However, systematic identification of multitarget compounds has been difficult using traditional in vitro screening assays. New approaches to phenotypic profiling in zebrafish can help researchers identify novel compounds with complex polypharmacology. For example, large-scale behavior-based chemical screens can rapidly identify large numbers of structurally diverse and phenotype-related compounds. Once these compounds have been identified, a systems-level analysis of their structures may help to identify statistically enriched target pathways. Together, systematic behavioral profiling and multitarget predictions may help researchers identify new behavior-mod...
In-vivo phenotypic screening in larval zebrafish has shown much promise for neuroactive drug discove...
A major hindrance for the development of psychiatric drugs is the prediction of how treatments can a...
A major hindrance for the development of psychiatric drugs is the prediction of how treatments can a...
A major obstacle for the discovery of psychoactive drugs is the inability to predict how small molec...
Many psychiatric drugs act on multiple targets and therefore require screening assays that encompass...
Most neuroactive drugs were discovered through unexpected behavioral observations. Systematic behav...
Many psychiatric drugs act on multiple targets and therefore require screening assays that encompass...
Neurological and psychiatric disorders (such as depression, neurodegeneration, and drug addiction) a...
The larval zebrafish has emerged asa vertebrate model system amenable to small molecule screens for ...
Zebrafish (Danio rerio) are rapidly emerging as an important model organism for aquatic neuropharmac...
Neuroactive compounds are crucial tools in drug discovery and neuroscience. However, discovering mec...
A major obstacle for the discovery of psychoactive drugs is the inability to predict how small molec...
To discover new molecules or review the biological activity and toxicity of therapeutic substances, ...
The zebrafish (Danio rerio) has recently become a common model in the fields of genetics, environmen...
Identifying novel marine-derived neuroactive chemicals with therapeutic potential is diffcult due to...
In-vivo phenotypic screening in larval zebrafish has shown much promise for neuroactive drug discove...
A major hindrance for the development of psychiatric drugs is the prediction of how treatments can a...
A major hindrance for the development of psychiatric drugs is the prediction of how treatments can a...
A major obstacle for the discovery of psychoactive drugs is the inability to predict how small molec...
Many psychiatric drugs act on multiple targets and therefore require screening assays that encompass...
Most neuroactive drugs were discovered through unexpected behavioral observations. Systematic behav...
Many psychiatric drugs act on multiple targets and therefore require screening assays that encompass...
Neurological and psychiatric disorders (such as depression, neurodegeneration, and drug addiction) a...
The larval zebrafish has emerged asa vertebrate model system amenable to small molecule screens for ...
Zebrafish (Danio rerio) are rapidly emerging as an important model organism for aquatic neuropharmac...
Neuroactive compounds are crucial tools in drug discovery and neuroscience. However, discovering mec...
A major obstacle for the discovery of psychoactive drugs is the inability to predict how small molec...
To discover new molecules or review the biological activity and toxicity of therapeutic substances, ...
The zebrafish (Danio rerio) has recently become a common model in the fields of genetics, environmen...
Identifying novel marine-derived neuroactive chemicals with therapeutic potential is diffcult due to...
In-vivo phenotypic screening in larval zebrafish has shown much promise for neuroactive drug discove...
A major hindrance for the development of psychiatric drugs is the prediction of how treatments can a...
A major hindrance for the development of psychiatric drugs is the prediction of how treatments can a...